Sorrento Therapeutics Investor
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Founded Date:
2006-01-01
Total Funding:
264418495.0
Investor Type:
N/A
Employee Number:
101-250
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Technology:
Others
Last Funding Type:
Post-IPO Equity
Acquisitions Number:
Made Acquisitions
Investors Number:
1
Last Funding Date:
2019-10-09
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Estimated Revenue:
$1M to $10M